Advertisement

GI & Endoscopy

Southlake, Texas-based GI Alliance has finalized its physician-led buyout facilitated by a $785 million investment from private equity firm Apollo Hybrid Value.

Advertisement

Biopharmaceutical company Takeda has announced the launch of its Cdpath program, which uses a blood test to predict someone's potentiral risk for developing serious Crohn's disease related complications within the next three years, according to a Sept. 14 press release…

Costs of procedures vary between ASCs and HOPDs, with GI procedures for those with original Medicare and no supplement being cheaper at ASCs, according to data from Medicare.gov.

Advertisement